Hypomethylating agent as first-line treatment for acute myeloid leukemia: Systematic review

被引：0
|
作者：
Jhoputri, Caroline Fricilia [1 ]
Tandokallo, Felicia [1 ]
Kosayuz, Sherina [1 ]
Atmaja, William Surya [1 ]
Kurniawan, Andree [2 ]
机构：
[1] Pelita Harapan Univ, Fac Med, Tangerang, Indonesia
[2] Pelita Harapan Univ, Dept Internal Med, Fac Med, Tangerang, Indonesia
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.343
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P12-2
引用
收藏
页码：S1446 / S1446
页数：1
相关论文
共 50 条
  • [21] Arsenic trioxide as first-line treatment for acute promyelocytic leukemia
    Leu, Lily
    Mohassel, Leila
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (21) : 1913 - 1918
  • [22] Gemtuzumab Ozogamicin as First-Line Treatment in Patients Aged 70 Years or Older With Acute Myeloid Leukemia
    McHayleh, Wassim
    Foon, Kenneth
    Redner, Robert
    Sehgal, Rajesh
    Raptis, Anastasios
    Agha, Mounzer
    Luong, Minh
    Schlesselman, James J.
    Boyiadzis, Michael
    CANCER, 2010, 116 (12) : 3001 - 3005
  • [23] DECITABINE AS THE FIRST-LINE TREATMENT FOR ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA; A SINGLE CENTER EXPERIENCE IN KOREA
    Lee, J.
    Park, H.
    Cho, H.
    Jang, J.
    Kim, S. J.
    Kim, Y.
    Kim, J. S.
    Cheong, J. W.
    Min, Y. H.
    HAEMATOLOGICA, 2015, 100 : 658 - 658
  • [24] Multicenter, Phase II Study of Decitabine for the First-Line Treatment of Older Patients With Acute Myeloid Leukemia
    Cashen, Amanda F.
    Schiller, Gary J.
    O'Donnell, Margaret R.
    DiPersio, John F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (04) : 556 - 561
  • [25] Outcomes of relapsed or refractory acute myeloid leukemia after front-line hypomethylating agent and venetoclax regimens
    Maiti, Abhishek
    Rausch, Caitlin R.
    Cortes, Jorge E.
    Pemmaraju, Naveen
    Daver, Naval G.
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Naqvi, Kiran
    Ohanian, Maro
    Short, Nicholas J.
    Alvarado, Yesid
    Kadia, Tapan M.
    Takahashi, Koichi
    Yilmaz, Musa
    Jain, Nitin
    Kornblau, Steven
    Montalban-Bravo, Guillermo
    Sasaki, Koji
    Andreeff, Michael
    Bose, Prithviraj
    Ferrajoli, Alessandra
    Issa, Ghayas C.
    Jabbour, Elias J.
    Masarova, Lucia
    Thompson, Philip A.
    Wang, Sa
    Konoplev, Sergej
    Pierce, Sherry A.
    Ning, Jing
    Qiao, Wei
    Welch, John S.
    Kantarjian, Hagop M.
    DiNardo, Courtney D.
    Konopleva, Marina Y.
    HAEMATOLOGICA, 2021, 106 (03) : 894 - 898
  • [26] Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease
    Sanber, Khaled
    Ye, Kevin
    Tsai, Hua-Ling
    Newman, Matthew
    Webster, Jonathan A.
    Gojo, Ivana
    Ghiaur, Gabriel
    Prince, Gabrielle T.
    Gondek, Lukasz P.
    Smith, B. Douglas
    Levis, Mark J.
    DeZern, Amy E.
    Ambinder, Alexander J.
    Dalton, William B.
    Jain, Tania
    LEUKEMIA & LYMPHOMA, 2023, 64 (04) : 846 - 855
  • [27] Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naive acute myeloid leukemia
    Gangat, Naseema
    Johnson, Isla
    McCullough, Kristen
    Farrukh, Faiqa
    Al-Kali, Aref
    Alkhateeb, Hassan
    Begna, Kebede
    Mangaonkar, Abhishek
    Litzow, Mark
    Hogan, William
    Shah, Mithun
    Patnaik, Mrinal
    Pardanani, Animesh
    Tefferi, Ayalew
    HAEMATOLOGICA, 2022, 107 (10) : 2501 - 2505
  • [28] Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia
    Hehlmann, Ruediger
    Berger, Ute
    Pfirrmann, Markus
    Heimpel, Hermann
    Hochhaus, Andreas
    Hasford, Joerg
    Kolb, Hans-Jochem
    Lahaye, Tanja
    Maywald, Ole
    Reiter, Andreas
    Hossfeld, Dieter K.
    Huber, Christoph
    Loeffler, Helmut
    Pralle, Hans
    Queisser, Wolfgang
    Tobler, Andreas
    Nerl, Christoph
    Solenthaler, Max
    Goebeler, Mariele E.
    Griesshammer, Martin
    Fischer, Thomas
    Kremers, Stephan
    Eimermacher, Hartmut
    Pfreundschuh, Michael
    Hirschmann, Wolf-Dietrich
    Lechner, Klaus
    Wassmann, Barbara
    Falge, Christiane
    Kirchner, Hartmut H.
    Gratwohl, Alois
    BLOOD, 2007, 109 (11) : 4686 - 4692
  • [29] Is drug treatment superior to allografting as first-line therapy in chronic myeloid leukemia?
    Hughes, Timothy
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (01): : 14 - 15
  • [30] Is drug treatment superior to allografting as first-line therapy in chronic myeloid leukemia?
    Timothy Hughes
    Nature Clinical Practice Oncology, 2008, 5 : 14 - 15
12345